Michael R. Kurman, M.D., has spent over thirty years in the oncology drug development field. He is a board-certified medical oncologist who practiced community oncology in New Jersey where he participated as an investigator in oncology clinical trials sponsored by the Eastern Cooperative Oncology Group (ECOG) and the Memorial Adjunct Staff Oncology Group (MASOG). During his career in the pharmaceutical industry, he has held positions of progressive responsibility at large-pharma, emerging-pharma and CRO companies. Dr. Kurman received his bachelor’s degree summa cum laude in biology from Syracuse University and his M.D. degree from Cornell University Medical College. He received his training in internal medicine at the State University of New York – Upstate Medical Center, and his oncology training at Mt. Sinai Medical Center in New York.
Dr. Kurman has served on the scientific advisory boards and the boards of directors of several companies. He is also a member of the Syracuse University Biology Alumni Advisory Board and is a member of several professional societies. He has held teaching positions at New York University and at Stevens Institute. He is the past president of the Board of Health of Upper Saddle River, NJ and a past commissioner of the Northwest Bergen Regional Health Commission.